This section presents pharmaceutical projects that are announced from time-to-time around the world.
TFF Pharmaceuticals, Inc plans to expand its R D opeartions with the opening of new Austin facility located in Texas, USA The new research and development facility constructed with an area covering 3,500 square feet will increase the total lab space
Synthego plans to construct new NextGeneration Manufacturing Facility The facility is designed to speed up the manufacturing of cell and gene therapies The new facility will be located at San Francisco, USA
Merck plans to expand membrane and filtration manufacturing capabilities The two new facilities will be located in Ireland The construction consist of two new projects including expansion of membrane manufacturing capacity in Carrigtwohill and new manufacturing facility
Eli Lilly and Company Invests US$$21 billion for the construction of new manufactruing facility The two new manufacturing sites will be located at Indianas LEAP Lebanon Innovation and the other at Research District in Boone County
Vertex Pharmaceuticals Incorporated plans for the construction of new manufacturing facility The site will be loacted at Boston Seaport, US The new stateoftheart cell and genetic therapies research and clinical manufacturing site is laid with an area covering 344,000 square foot
PCI Pharma Services plans for the expansion of manufacturing facility with the addition of worldclass facilities The facility will be located at Bedford, USA The new manufacturing facility will be constructed with an area covering 50,000 square foot to increase breadth of services
UCB plans to expand its footprint with the opening of new stateoftheart gene therapy facility The new facility will be located in Belgium The new facility enhances current world class facilities and cuttingedge scientific platforms including biologics, small molecules, and peptides
Amgen announces plans for the construction of new manufacturing facility The new plant will be dedicated in manufacturing medicines to treat serious illnesses such as cancer and heart disease The new manufacturing facility will be added to the existing robust biomanufacturing ecosystem It ensures to produce
Piramal Pharma Solutions plans for the expansion of manugacturing facility in Scotland and upgradation of current Active Pharmaceutical Ingredient API manufacturing in Morpeth, England The construction of new stateoftheart AntibodyDrug Conjugate ADCis due to various pipeline products moving to commercial scale
Eli Lilly plans for the construction of new manufacturing site The new site will be located in North California The new facility will be designed with latest technologies to manufacture parenteral injectable products and devices including medicines
